ATE450602T1 - Stemzelldifferenzierung induzierende promoter - Google Patents

Stemzelldifferenzierung induzierende promoter

Info

Publication number
ATE450602T1
ATE450602T1 AT01972471T AT01972471T ATE450602T1 AT E450602 T1 ATE450602 T1 AT E450602T1 AT 01972471 T AT01972471 T AT 01972471T AT 01972471 T AT01972471 T AT 01972471T AT E450602 T1 ATE450602 T1 AT E450602T1
Authority
AT
Austria
Prior art keywords
diseases
cell differentiation
cells
stem cell
stem
Prior art date
Application number
AT01972471T
Other languages
English (en)
Inventor
Bang Luu
Eliane Mohier
Masashi Yamada
Yukie Suma
Hiroto Suzuki
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000304746A external-priority patent/JP2002068973A/ja
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Application granted granted Critical
Publication of ATE450602T1 publication Critical patent/ATE450602T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/713—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT01972471T 2000-10-04 2001-09-19 Stemzelldifferenzierung induzierende promoter ATE450602T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000304746A JP2002068973A (ja) 2000-06-16 2000-10-04 幹細胞分化誘導促進剤
PCT/JP2001/008136 WO2002029014A2 (en) 2000-10-04 2001-09-19 Stem cell differentiation-inducing promoter

Publications (1)

Publication Number Publication Date
ATE450602T1 true ATE450602T1 (de) 2009-12-15

Family

ID=18785739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01972471T ATE450602T1 (de) 2000-10-04 2001-09-19 Stemzelldifferenzierung induzierende promoter

Country Status (6)

Country Link
US (1) US20040115810A1 (de)
EP (1) EP1322748B1 (de)
AT (1) ATE450602T1 (de)
CA (1) CA2424207C (de)
DE (1) DE60140685D1 (de)
WO (1) WO2002029014A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4861560B2 (ja) * 2001-02-19 2012-01-25 株式会社明治 糖尿病合併症治療剤
US7235700B2 (en) * 2003-03-28 2007-06-26 Meiji Dairies Corporation Process for producing cyclohexenone long-chain alcohols
US20080125495A1 (en) * 2004-11-25 2008-05-29 Meiji Dairies Corporation Ameliorant For Renal Insufficiency
EP2521587B1 (de) * 2010-01-08 2020-04-08 Wake Forest University Health Sciences Freisetzungssystem
CA2828705A1 (en) 2011-03-07 2012-09-13 Wake Forest University Health Sciences Delivery system
US11485696B2 (en) 2016-01-22 2022-11-01 Taiho Pharmaceutical Co., Ltd. Manufacturing method for high-purity cyclohexenone long-chain alcohol
CN107032975B (zh) * 2016-02-03 2022-06-28 大鹏药品工业株式会社 一种高纯度环己烯酮长链醇的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69811905T2 (de) * 1997-08-13 2003-11-06 Meiji Milk Products Co. Ltd., Tokio/Tokyo Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel

Also Published As

Publication number Publication date
WO2002029014A3 (en) 2002-12-19
WO2002029014A2 (en) 2002-04-11
CA2424207C (en) 2013-03-26
EP1322748B1 (de) 2009-12-02
US20040115810A1 (en) 2004-06-17
DE60140685D1 (de) 2010-01-14
EP1322748A2 (de) 2003-07-02
CA2424207A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
CA1126158A (en) Cosmetic composition containing kojic acid ester
JP2007161591A (ja) メラニン産生阻害皮膚外用剤
AU2003222049B2 (en) Prostaglandin F2 alpha analogs in combination with antimicrobials for treating glaucoma
TW200602031A (en) Antiinflammatory and pain-relieving agent for external, use
BR0209320A (pt) ésteres de uridina farmaceuticamente ativos
PL1725536T3 (pl) Pochodne imidazoliny mające czynność CB1-antagonistyczną
TW201201864A (en) Preparation derived from an in vitro culture of dedifferentiated non-elicited argan cells, their use for the treatment of skin aging, inflammation and healing, and method for obtaining them
ATE450602T1 (de) Stemzelldifferenzierung induzierende promoter
US9463338B2 (en) Derivatives of the sinapinic acid
KR20200074922A (ko) 활성산소 공여체를 유효성분으로 포함하는 모유두 세포 배양용 조성물 및 이의 용도
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
KR20150067130A (ko) 조직 보존액 및 조직 보존 방법
DE50211978D1 (de) Stabilisierung oxidations- und/oder uv-empfindlicher wirkstoffe
KR20180034291A (ko) 통증이 경감되는 골관절염 치료용 키트
KR101693923B1 (ko) 잘피 식물 세포 배양 추출물을 함유한 항염 및 항노화 효과를 지닌 피부 외용제 조성물 및 그 제조방법
DE60238666D1 (de) Cyclohexenon derivate zur behandlung der diabetischen neuropathie
KR100786300B1 (ko) 3,4-메틸렌디옥시벤젠 또는 3,4-에틸렌디옥시벤젠 모핵을가지는 4-치환된 벤조산 유도체 화합물을 함유하는항노화용 화장료 조성물
KR20040053907A (ko) 열충격 단백질 생성 촉진 성분 및 이를 함유하는 피부미백용 외용제 조성물
KR20090052096A (ko) 이끼 추출물 또는 그 유효 성분인 뎁시돈 또는 뎁시돈유도체를 함유하는 항노화 피부 외용제 조성물
US8859819B2 (en) Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof
BR0010525A (pt) cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase
ES2096208T3 (es) Derivados de octahidronaftaleno oxima para la inhibicion de la biosintesis de colesterol, su preparacion y utilizacion.
AU2001260695A1 (en) Malto-oligosaccharide derivatives and use thereof
WO2002044403A3 (en) Markers for testing analogs of vitamin d and therapeutical uses
KR100412114B1 (ko) 프럭토스-1,6-디포스페이트 유도체 및 이의 제조방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties